Bionova Scientific aims to set up new Plasmid DNA GMP facility neat Houston, US
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
This significant achievement includes an initial order from GCPL valued at a substantial Rs. 2.4 crore
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
The collaboration aims to bolster healthcare entrepreneurship
Subscribe To Our Newsletter & Stay Updated